Rivas LFE, Brito DH

Language: Spanish
References: 0
Page: 69-72
PDF size: 219.20 Kb.

ABSTRACT

Allergic bronchopulmonary aspergillosis (ABA) is the most common cause of allergic bronchopulmonary mycosis and is an exaggerated immunological response to the colonization of the airways for any of the five species of aspergillus. Such immunological response is due predominantly to an immediate hypersensitivity or to the development of immune complexes. ABA occurs in atopic patients and is associated with asthma; its incidence varies from 7% to 14% in asthmatic patients treated with corticosteroids and up to 10% in cystic fibrosis patients. There are well defined criteria to establish the diagnosis. The cornerstones of the treatment are corticosteroids and antifungal drugs.